Insider trading · Q3 2026 · CIK 1484612

Outset Medical, Inc. (OM) insider trading.

In Q3 2026, insiders at Outset Medical, Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $47K.

Transactions
3
Purchases (P)
0
Sales (S)
3
Net shares, P minus S
-10,612
Insiders
3
Last filed
2026-08-18

Insiders

InsiderRelationshipTransactionsBuysSales
Gaeta ReneeOfficer · Chief Financial Officer101
Brottem John L.Officer · General Counsel101
Trigg LeslieDirector, Officer · Chair and CEO101

Transactions

3 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-17Gaeta ReneeS (D)4,543$4.39180,840Form 4
2026-08-17Brottem John L.S (D)2,632$4.3987,475Form 4
2026-08-17Trigg LeslieS (D)3,437$4.39194,597Form 4

Transaction codes in this quarter

Get OM insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1484612&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · OM company page · Outset Medical, Inc. on SEC.gov

Questions

Are insiders buying or selling Outset Medical, Inc. (OM)?

In Q3 2026, insiders at Outset Medical, Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $47K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Outset Medical, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/om.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.